Home/Filings/4/0001735276-25-000072
4//SEC Filing

BONNEY MICHAEL W 4

Accession 0001735276-25-000072

CIK 0001178670other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:17 PM ET

Size

33.4 KB

Accession

0001735276-25-000072

Insider Transaction Report

Form 4
Period: 2025-05-15
Transactions
  • Sale

    Common Stock

    2025-05-15$278.01/sh1,239$344,45421,755 total
  • Sale

    Common Stock

    2025-05-15$283.83/sh1,617$458,95316,804 total
  • Sale

    Common Stock

    2025-05-15$269.79/sh245$66,09926,531 total
  • Sale

    Common Stock

    2025-05-15$275.63/sh301$82,96524,257 total
  • Sale

    Common Stock

    2025-05-15$282.81/sh1,728$488,69618,421 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-05-1511,2500 total
    Exercise: $131.21From: 2016-06-01Exp: 2025-06-01Common Stock (11,250 underlying)
  • Sale

    Common Stock

    2025-05-15$267.14/sh549$146,66027,505 total
  • Sale

    Common Stock

    2025-05-15$271.68/sh431$117,09426,100 total
  • Sale

    Common Stock

    2025-05-15$282.03/sh802$226,18820,149 total
  • Sale

    Common Stock

    2025-05-15$280.03/sh432$120,97321,323 total
  • Exercise/Conversion

    Common Stock

    2025-05-15$131.21/sh+11,250$1,476,11328,054 total
  • Sale

    Common Stock

    2025-05-15$268.56/sh729$195,78026,776 total
  • Sale

    Common Stock

    2025-05-15$273.16/sh660$180,28625,440 total
  • Sale

    Common Stock

    2025-05-15$273.75/sh882$241,44824,558 total
  • Sale

    Common Stock

    2025-05-15$277.16/sh1,263$350,05322,994 total
  • Sale

    Common Stock

    2025-05-15$281.10/sh372$104,56920,951 total
Holdings
  • Common Stock

    (indirect: By Trust)
    4,000
Footnotes (17)
  • [F1]This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025.
  • [F10]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $277.77 to $278.43. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F11]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $279.26 to $280.17. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F12]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $280.38 to $281.37. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F13]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $281.39 to $282.26. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F14]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $282.40 to $283.37. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F15]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $283.54 to $284.22. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F16]The shares of ALNY common stock were purchased by the Michael W. Bonney Revocable Trust, of which the reporting person is trustee.
  • [F17]The stock option was fully vested as of June 1, 2016.
  • [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $266.87 to $267.72. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $268.28 to $269.16. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F4]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $269.53 to $269.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F5]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $271.44 to $272.10. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F6]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $272.60 to $273.59. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F7]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $273.61 to $274.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F8]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $275.11 to $276.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F9]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $276.55 to $277.45. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Issuer

ALNYLAM PHARMACEUTICALS, INC.

CIK 0001178670

Entity typeother

Related Parties

1
  • filerCIK 0001219016

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:17 PM ET
Size
33.4 KB